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Abstract
17ß-Estradiol, an epigenetic modulator, is involved in the increased prevalence of migraine in women. Together with the
prophylactic efficacy of valproate, which influences DNA methylation and histone modification, this points to the
involvement of epigenetic mechanisms. Epigenetic studies are often performed on leukocytes, but it is unclear to what
extent methylation is similar in other tissues. Therefore, we investigated methylation of migraine-related genes that might
be epigenetically regulated (CGRP-ergic pathway, estrogen receptors, endothelial NOS, as well as MTHFR) in different
migraine-related tissues and compared this to methylation in rat as well as human leukocytes. Further, we studied whether
17ß-estradiol has a prominent role in methylation of these genes. Female rats (n = 35) were ovariectomized or sham-
operated and treated with 17b-estradiol or placebo. DNA was isolated and methylation was assessed through bisulphite
treatment and mass spectrometry. Human methylation data were obtained using the Illumina 450k genome-wide
methylation array in 395 female subjects from a population-based cohort study. We showed that methylation of the Crcp,
Calcrl, Esr1 and Nos3 genes is tissue-specific and that methylation in leukocytes was not correlated to that in other tissues.
Interestingly, the interindividual variation in methylation differed considerably between genes and tissues. Furthermore we
showed that methylation in human leukocytes was similar to that in rat leukocytes in our genes of interest, suggesting that
rat may be a good model to study human DNA methylation in tissues that are difficult to obtain. In none of the genes a
significant effect of estradiol treatment was observed.
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Introduction
Migraine is a neurovascular disorder affecting 8–17% of the
population [1,2]. Little is known about the cause of migraine and
the prophylactic medication that is used to prevent migraine is
only effective in half of the patients [3]. Family studies show a
heritability of ,40% [4,5] and a monogenetic inheritance pattern
has only been identified for familial hemiplegic migraine. Hence,
there may be a major contribution of environmental (including
hormonal) influences, possibly via epigenetic mechanisms. The
methylene tetrahydrofolate reductase gene (MTHFR), encoding an
important protein of the DNA methylation cycle, has been
suggested to be involved in migraine [6,7], although genome-wide
association studies did not confirm this. However, they pointed to
other genes involved in epigenetic mechanisms [8–10]. Moreover,
the migraine prophylactic valproate, inhibits histone deacetylation
as well as DNA methylation [11]. Finally, 17b-estradiol, which
seems to be responsible for the 2–3 times higher prevalence of
migraine in women compared to men, may exert at least part of its
effects via epigenetic mechanisms [12,13]. Thus, DNA methyla-
tion may be involved in migraine pathophysiology.
DNA methylation occurs at cytosines of CpG dinucleotides,
often localized in CpG rich regions called CpG islands [14]. CpG
island methylation is changed in different types of cancer, during
aging, and probably also during the menstrual cycle [15–18].
Environmental factors that might be responsible for these
epigenetic mechanisms include female hormones and nutrition
[19,20].
DNA methylation can differ greatly between tissues, so ideally it
should be studied in the tissue of interest. For complex brain
diseases like migraine, this is technically impossible in humans.
Yet, blood can be derived easily, and thus if the DNA methylation
pattern of leukocytes is correlated to that of other tissues, this
would allow conclusions from methylation studies in leukocytes.
The aim of our study was to compare the methylation of genes
that are probably involved in the generation of a migraine attack
and might be epigenetically regulated [21,22], as well as to
examine the role of 17ß-estradiol in the methylation of our genes
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of interest. We focussed on the CGRP-ergic system because of its
prominent role in migraine [23] We investigated DNA methyla-
tion in the Calcitonin related peptide alpha (Calca), receptor
activity-modifying protein 1 (Ramp1), calcitonin receptor compo-
nent protein (Crcp), calcitonin receptor-like receptor (Calcrl),
upstream stimulating factor 2 (Usf2), Estrogen receptor 1 (Esr1),
G-protein coupled estrogen receptor 1 (Gper), nitric oxide synthase
3 (Nos3)) and Mthfr genes in several tissues relevant to the
pathophysiology of migraine (dura mater, trigeminal ganglion and
trigeminal caudal nucleus). We investigated methylation in
leukocytes and aorta as a peripheral control. To investigate
whether DNA methylation in rats may be representative of that in
humans, we also studied DNA methylation in leukocytes obtained
from healthy human females.
Materials and Methods
Ethics statement
The animal experiments were performed in our laboratory with
permission of the ethics committee of the Erasmus Medical Center
in Rotterdam, The Netherlands (Permit Number: EMC2345(127-
11-02)). All surgeries were performed under sodium pentobarbital
anesthesia and all effort was made to minimize suffering.
The human blood samples were obtained from the Rotterdam
Study [24], which has been approved by the institutional review
board (Medical Ethics Committee) of the Erasmus Medical Center
and by the review board of The Netherlands Ministry of Health,
Welfare and Sports. All subjects provided written informed
consent.
Animals
Female Sprague Dawley rats (Harlan Netherlands, Horst, The
Netherlands) (N= 11–12 per group, weight at the start of the study
,250 g) (See Table S1 in File S1) were kept at room temperature
(22uC) at a 12/12 hours dark/light cycle with unlimited access to
food and water in their home cages. The animals were
anesthetized (50 mg/kg) and ovariectomized or sham-treated on
day 1 of the study. After 7 days, a pellet releasing placebo or 17b-
estradiol (21-day release pellet, 12 mg/day, Innovative Research,
USA) was implanted subcutaneously in the neck. Blood samples
were collected on day 1, 7 and 21 for CGRP and hormone
measurements (See Table S2 in File S1). On day 21, the animals
were sacrificed via an overdose of sodium pentobarbital (200 mg/
kg). A leukocyte differentiation count was performed to verify
whether the proportion of different types of leukocytes was the
same for all animals. 0.5 ml whole blood, dura mater, trigeminal
ganglia, caudal nuclei and a 5-mm segment of thoracic aorta were
snap frozen in liquid nitrogen and stored at 280uC for DNA
isolation. A vaginal smear was taken at all three time points to
establish the phase of the estrous cycle according to proportions of
epithelial cells, cornified cells and leukocytes present in the smear.
Because an epigenetic study as in the current experiments has not
been performed previously, we based the number of animals on
our previous results, showing increased vascular endogenous
CGRP responses after treatment with 17b-estradiol [25] and
explored whether differences in DNA methylation caused by 17b-
estradiol can be demonstrated in this model.
DNA methylation measurements
DNA of leukocytes, thoracic aorta, dura mater, trigeminal
ganglia and caudal nuclei from all animals was isolated (DNeasy,
Qiagen, Germantown, MD, USA) and quantified (Nanodrop,
Thermo Scientific, Wilmington, DE, USA).
CpG islands of the genes of interest were determined using
UCSC (http://genome.ucsc.edu/) and Ensemble genome brows-
ers (http://www.ensembl.org). Primers were designed for each
CpG island located in the promoter region of the genes of interest
with the EpiDESIGNER primer design software (Sequenom, San
Diego, CA, USA, Table 1). When the CpG island could not be
covered in total, multiple primer sets were designed to cover the
largest possible part of the CpG Island. With the BiSearch web
server [26] primer sets were checked for having only one product.
500 ng DNA of all tissue samples was treated with bisulfite (EZ-
96 DNA-methylation kit (Shallow), Zymo Research, Irvine, CA,
USA) for 16 hours to convert all non-methylated cytosines into
uracil nucleotides. After bisulfite conversion PCR, reverse
transcription and uracil specific cleavage was performed. For
quantitative DNA methylation measurements the MassARRAY
EpiTYPEr was used (Sequenom, San Diego, CA, USA). 2.5 mg of
low methylated and 2.5 mg high methylated genomic rat DNA
(EpigenDx, Hopkinton, MA, USA) were mixed into 0%, 25%,
50%, 75% and 100% methylated DNA as a control and also
treated with bisulfite. To check the accuracy of the methylation
measurements, methylation of a standard curve, of which the % of
methylation is known (0–100%, increasing in steps of 10%), was
measured for all amplicons (See Figure S1 in File S1). After the
validation steps, a PCR was performed in triplo for all amplicons
on the bisulfite-treated samples. Percentage methylation for each
CpG in all genes and tissues was calculated with Sequenom
EpiTYPER software (MassARRAY EpiTYPER Analyzer software
v1.0, build1.0.6.88 Sequenom, Inc, San Diego, USA). Samples
were excluded when the standard deviation of triplos was larger
than 10%.
Genome-wide methylation study in humans
DNA methylation profiles from whole blood were assessed in a
subset of 395 healthy women (age $45) from the Rotterdam
Study-III, a population-based cohort study in the Netherlands.
The design and rationale of the study has been published
previously [24]. Samples were excluded when showing a low
detection rate (,99%), incomplete bisulfite conversion, or gender
swaps. Probes with a detection p-value .0.01 in .1% samples,
were filtered out. b-values for the two assay-types on the array
were corrected with SWAN (Subset-Within-Array-Normalization).
Mean and standard deviation for the probes in the equivalent
human genomic regions were calculated for 395 samples that
passed quality control filters.
Data analysis
Calculations of differences in methylation and correlation
between tissues were performed using SPSS software. The linear
mixed model was used to estimate the size and standard errors of
the effects of tissue and treatment. The model contains random
effects for the individual rats, to correct for the strong correlations
between CpGs within a gene. Typically, when one CpG shows a
low (or high) level of methylation for a chosen rat, all the other
CpGs show a low (or high) level as well. A strong example is shown
in Fig. 1, for the Crcp gene in the trigeminal ganglion. The profiles
for different rats run more or less in parallel, but at quite different
levels. Subtracting the mean of all CpGs per rat removes the
differences almost completely. The computations were done with
the R system [27], version 2.15.2, using the function lmer in the
library lme4.
Methylation of Migraine-Related Genes in Rat
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Results
DNA methylation measurements
Because all CpGs per CpG island that we studied were strongly
correlated, we calculated the mean methylation of a CpG island
and used these values for further analysis (see paragraph 2.4,
Statistics). DNA methylation below 5% was observed for the Calca,
Ramp1, Usf2 and Mthfr genes in all tissues (Table 2). DNA
methylation higher than 90%, was observed for the Gper gene in all
tissues (Table 2). DNA methylation differed substantially between
tissues for the Nos3, Esr1, Crcp and Calcrl genes. Nos3 showed a two
times significantly higher DNA methylation in leukocytes than in
the other tissues. Methylation of the Crcp gene was high in aorta,
leukocytes and trigeminal caudal nucleus, and significantly lower
in dura mater and trigeminal ganglion. The Calcrl gene showed
low methylation in leukocytes, intermediate methylation in dura
Table 1. Primers and conditions for PCR on CpG island located in the promoter region of genes of interest.
Amplicon Primer Sequence Amplicon size (bp)
Number of
analyzed CpG’s
Calca-part 1 Forward-TTTAAATGGTGTTATTTTGTTAGATGTT Reverse-TAAACAAAAACCTCAAAACTCACCT 282 7
Calca-part 2 Forward-GTAATTGTGGTTGTTGGTTTTTGTT Reverse-CACCAAATAAACCCTAAAATTCCTA 405 7
Ramp1 Forward-GGGGGTTATGGTAAGTAGAGTTT Reverse-TTACAAAACAAACCCCAAAATAACT 294 17
Crcp Forward-TTAGTAGTGGGTTTAGGAAGAGAGTG Reverse-CTAAAAAACAAAATTCTAAATACACAAAAC 290 11
Calcrl Forward-GGGTTTTGTTGTTTGGATTTTA Reverse-TCCAAAAACTTACCTTATAACCTATTCA 244 2
Usf2 Forward-GGTAGTAGTGTTGATTTTGGTGGG Reverse-TCACCTAACCTCCATTACTCTCTATAC 411 15
Esr1-part 1 Forward-GGTAGTAGGGTATTTGGTGGTTATG Reverse-CAACTCAAAATACCCATAAAAAAAA 321 9
Esr1-part 2 Forward-TTTTTTGATTTTTTAGAAGGGTGG Reverse-TAATCTAAAAACTTTCCCCCAACTC 293 13
Gper1-part 1 Forward-GAAGATTATTTTTAGGGTTTTTTGTTTG Reverse-ACACCTTCATATCCCTCTTCCTACAA 397 7
Gper1-part 2 Forward-TTGTTGTATATGTTGATTTGTAGGAAGA Reverse-CCCAAACCTATACTTCATCAACCTAA 152 2
Nos3 Forward-TTTTTGTAAAGAAAAATTTTGGGTG Reverse-CACAATAAAAACTACCCCTAAACCT 404 11
Mthfr Forward-GGGGTGATAGTTATTATAAGTTTATAGGTT Reverse-TTAACTAACTTCCCAAAAAACCTCC 244 12
A 10mer (aggaagagag) sequence was added to the forward primers and a T7 sequence (cagtaatacgactcactatagggagaaggct) to the reverse primers. The primers were
obtained from Invitrogen (Life Technologies Corporation, Carlsbad, CA, USA).
doi:10.1371/journal.pone.0087616.t001
Figure 1. Methylation of the Crcp gene in the trigeminal ganglion. Methylation of each studied CpG of the promoter region of the Crcp gene
is shown without correction for rat levels (upper panel) and with correction for rat levels (lower panel).
doi:10.1371/journal.pone.0087616.g001
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mater and trigeminal caudal nucleus and high methylation in
aorta and trigeminal ganglion. DNA methylation of Esr1 was
significantly higher in the aorta than in other tissues (Fig. 2 and
Table 2). Remarkable is that the variation in DNA methylation is
small in some tissues and large in others. This is not a tissue-
specific pattern, but it varies between tissues for the Nos3, Esr1,
Crcp and Calcrl genes, as illustrated by the differences in standard
deviation (Table 2).
Estradiol treatment did not induce any statistically significant
differences in DNA methylation in any of the examined genes in
any investigated tissue (Fig. 2). Therefore, the data of the different
treatment groups were pooled for further statistical analyses, where
treatment effect was not included.
The DNA methylation of leukocytes and that of the other tissues
were compared to each other for all genes. No correlation was
seen between DNA methylation in the leukocyte samples and
samples from other tissues (Table 3). A leukocyte differentiation
analysis was performed, but no influence was found of leukocyte
composition on methylation of blood samples for any of the genes
(data not shown).
Concordance of DNA methylation in human and rat
leukocytes
Human female DNA methylation data of our genes of interest
were obtained from a genome wide methylation array. Human
DNA methylation data of exactly the same genomic region of rat
Figure 2. DNAmethylation of Crcp, Calcrl, Esr1 and Nos3 in different tissues.Mean methylation of the promoter region of the Crcp (upper left
panel), Calcrl (upper right panel), Esr1 (lower left panel) and Nos3 (lower right panel) genes is shown for the different tissues studied. Each symbol
represents one animal and the different colors and symbols represent the treatment of the animals. Red circle: OVX+17b-estradiol; Green square:
OVX+placebo; Blue triangle: sham+placebo.
doi:10.1371/journal.pone.0087616.g002
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DNA was available for the CALCA, CALCRL, USF2, ESR1, GPER
and MTHFR genes. For the other genes, RAMP1, CRCP and NOS3,
the region studied in rat was very close (,100 bp) to the regions
studied in human. We observed comparable values of DNA
methylation in our genes of interest in human leukocytes as in rat
leukocytes; the two genes with a high percentage of DNA
methylation in the rat had also a high percentage of DNA
methylation in the human samples, while the seven genes with a
low percentage of DNA methylation were also concordant
between the rat and human samples (Table 4, Fig. 3).
Discussion
DNA methylation and gene expression across tissues
DNA methylation and histone modifications, making the DNA
accessible or locked for transcriptional regulation, are responsible
for physiological processes like stem cell differentiation. Therefore,
CpG island methylation may be similar between tissues but can
also differ substantially. DNA methylation of the Calca, Ramp1,
Usf2 and Mthfr genes was low in all tissues. Not taking into account
other regulatory mechanisms, expression of these proteins would
thus be expected in all investigated tissues. Notwithstanding the
fact that tissue-specific information is not always available, all four
genes are indeed expressed in several brain and cardiovascular
tissues [28–33]. The expression in human leukocytes [34–37]
suggests the expression in rat leukocytes as well.
In contrast, DNA methylation of the CpG island of the Gper
gene was 90–94% in all investigated tissues, suggesting that
expression of this gene might be low or absent. However, Gper
mRNA is present in cells of the aorta [38] and in the central and
peripheral nervous system [39] But the quantitative extent of this
expression is unknown. Further, regulation of protein expression
might even occur at high percentages of DNA methylation.
Obviously, other regulatory mechanisms, such as histone modifi-
cations or non-epigenetic mechanisms like transcription factor
binding to specific regions on the DNA, may also have an
Table 2. Mean methylation of CpG islands of candidate genes in aorta, leukocytes, dura mater, trigeminal caudal nucleus and
trigeminal ganglion.
Aorta Leukocytes Dura Trigeminal Caudal Nucleus Trigeminal Ganglion
Mean ± SD (%) Mean ± SD (%) Mean ± SD (%) Mean ± SD (%) Mean ± SD (%)
Calca* 2.360.6 4.261.6 2.460.7 2.861.0 2.561.1
Ramp1* 2.360.5 2.860.8 2.360.5 3.260.7 2.560.6
Crcp* 84.362.4 91.062.5 82.161.6 41.1614.1 43.265.1
Calcrl* 70.6617.6 2.962.2 28.269.6 15.0613.5 69.6610.3
Usf2 1.560.3 1.760.6 1.560.3 1.560.3 1.660.3
Esr1* 13.462.6 3.460.9 4.360.9 4.161.3 3.060.8
Gper* 93.760.8 93.461.7 92.660.7 90.262.2 92.960.8
Nos3* 6.463.9 23.0614.6 9.765.1 7.166.0 6.165.6
Mthfr 2.060.4 2.060.6 1.960.5 2.260.6 1.960.4
*) Significant differences between tissue means are present within the respective gene. P-value ,0.0001.
doi:10.1371/journal.pone.0087616.t002
Table 3. Relationship of methylation of leukocytes with other tissues.
Methylation of leukocytes compared to other tissues (Pearsons r1)
Aorta Dura Trigeminal Caudal Nucleus Trigeminal Ganglion
Calca 20.23 20.33 20.38 20.01
Ramp1 0.26 0.64 0.40 0.40
Crcp 0.04 0.33 0.09 0.17
Calcrl 0.08 0.29 0.52 20.37
Usf2 0.07 0.50 0.07 20.06
Esr1 0.43 0.53 0.18 0.58
Gper 0.01 0.02 0.17 0.07
Nos3 0.02 0.18 20.36 20.38
Mthfr 0.33 20.09 20.02 0.13
1) The relevance of the correlations can best be appreciated from a prediction perspective. Assume that we are interested in estimating the mean amount of
methylation of some gene in some tissue. If we have no specific information, the best we can do is take the observed mean in our sample. The uncertainty is quantified
by the observed standard deviation (SD). If a linear relationship with the mean amount of methylation in blood exists, a prediction model could be derived. Using basic
statistical theory, one can show that the uncertainty is reduced to c * SD, where c follows form the formula c2 = 12r2, if r is the correlation coefficient. To get c = 0.5, thus
halving the uncertainty, r has to be as high as 0.87. Conversely, when r = 0.5, c = 0.87 and thus only a 13% reduction is obtained. For reliable prediction really high
correlations (e.g. r = 0.97 for c = 0.25) are needed.
doi:10.1371/journal.pone.0087616.t003
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additional effect on protein expression. Hence, DNA methylation
is not necessarily related to protein expression for every gene
[40,41].
Our results show that the variation in methylation differs
between tissues in the Crcp, Calcrl, Esr1 and Nos3 genes, which are
expressed in several brain and vascular tissues [32,42]. ESR1 and
NOS3 are also expressed in human leukocytes [43,44] Large
variations could result from contamination with other tissues, but
variations would then be expected to be small in tissues that are a
distinct anatomical entity, such as aorta and trigeminal ganglion.
Furthermore, outliers potentially caused by contaminated tissue,
should then be the same in all examined genes, which was not the
case. It would be tempting to quantitatively relate differences in
DNA methylation to differences in gene expression and subse-
quent translation into proteins in the different tissues. However,
such a quantification between tissues, which is clearly beyond the
scope of our study, would be hampered by the different
characteristics of the tissues studied, with the consequent lack of
a validated internal standard between tissues. Taken together, the
substantial variations in DNA methylation between tissues for Crcp,
Calcrl, Esr1 and Nos3 genes in some of the tissues (Fig. 2), suggests a
regulatory role for DNA methylation in the expression of these
genes in the respective tissues.
DNA methylation in leukocytes versus other tissues
DNA methylation is regularly examined in leukocytes with the
aim of discovering biomarkers for several diseases [45,46] because
of the difficulty of obtaining affected tissues. For example,
leukocyte DNA methylation is correlated to different types of
cancer [47–49]. In our study, there was no correlation between
DNA methylation of the candidate genes in leukocytes and that in
the other tissues. Thus, it can be concluded that leukocytes are not
Figure 3. Rat leukocyte DNA methylation compared to human
leukocyte DNA methylation. The methylation of DNA from rat
leukocytes is compared to methylation of DNA from human leukocytes
for different migraine-related genes. Our genes of interest that are high
methylated in rat leukocytes, are also high methylated in human
leukocytes and the genes that are low methylated in rat leukocytes are
also low methylated in human leukocytes.
doi:10.1371/journal.pone.0087616.g003
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representative for changes in DNA methylation in aorta, dura
mater, trigeminal caudal nucleus and trigeminal ganglion for the
migraine-related genes we investigated (Table 2).
Is the rat a valid model for human DNA methylation?
We studied whether DNA methylation of human leukocytes in
our genes of interest is similar to DNA methylation of rat
leukocytes. Since DNA methylation in human and rat leukocytes
was found to be concordant, we hypothesize that this might also be
the case for other tissues. This finding, combined with the obvious
limitations in obtaining human tissues, suggests that animal models
are relevant to study DNA methylation changes in specific tissues.
DNA methylation and environmental factors
DNA methylation may be influenced by environmental factors
like nutrition [50] and maternal care [51]. Hormones like 17b-
estradiol may also alter DNA methylation [52,53]. Interestingly,
female hormones probably play an important role in migraine as
migraine is much more common in females than in males
especially during the fertile part of their lives, and migraine attacks
in females often start at the day before menstruation [54]. It is well
known that estradiol affects epigenetic mechanisms [12,13]. In
addition, it potentiates the response to an important peptide in
migraine pathophysiology, calcitonin gene-related peptide (CGRP)
[24,25], which is widely expressed in the central and peripheral
nervous system [55]. We previously demonstrated that estrogen
increases vascular sensitivity to CGRP and trigeminal innervation
[25]. Estrogen can also modulate CGRP expression in the spinal
portion of the trigeminal caudal nucleus and the cervical spinal
cord [56,57]. How estrogen causes these effects is still unknown,
but a recent study showed that CGRP expression is epigenetically
regulated [21]. Epigenetic mechanisms like DNA methylation may
thus be involved in the differences in migraine prevalence between
men and women.
When examining mean values of DNA methylation of the three
different treatment groups (Fig. 2) some differences were observed
between the groups, but these were not statistically significant.
Because we are, to the best of our knowledge, the first to perform a
study on DNA methylation of candidate genes in our field, we
could not perform an adequate power calculation. We based our
group sizes on our previous studies using the same animal model
[25], where the same dose of and duration of treatment with 17b-
estradiol as in the current study were adequate to induce changes
in CGRP-ergic pathways. Furthermore, others have shown that
DNA methylation patterns can change within hours or days
[16,58]. A study with a similar design as our current study showed
that an environmental factor, bisphenol A, can increase methyl-
ation of the promoter region of the estrogen receptor [59],
indicating that the methods we applied are suitable to detect
changes in DNA methylation due to environmental factors.
The large variation in methylation in our investigated tissues is
likely to have reduced the statistical power of our study when
investigating the effects of 17ß-estradiol treatment. We observed a
maximal difference of 8% methylation with a standard deviation
of 18% between animals treated with 17b-estradiol and animals
treated with placebo (data not shown). Based on a post-hoc power
calculation, a group size of 318 animals would be needed to obtain
sufficient statistical power to investigate these hormone effects.
This is practically not feasible so another study setup, possibly an
in vitro study, falling beyond the scope of the current study, is
needed to investigate the effect of 17b-estradiol on DNA
methylation. Thus, with our experiment, we cannot categorically
exclude that the methylation of the genes that we have studied
may be influenced by 17ß-estradiol.
Relevance of CpG islands
Methylation of CpG islands in and close to promoter regions of
genes can cause a decrease in transcription of those genes during
development and in certain types of cancer, Therefore, the focus
in DNA methylation studies, including our current study, is often
on CpG islands [60,61]. CpG islands in or close to the promoter
region of a gene are only present in 60% of the genes. Also in our
case, there are genes that were of potential interest because they
are involved in CGRP and estrogen signalling, as for example
estrogen receptor 2 (Esr2) or the transient receptor potential cation
channel, subfamily V, member 1 (Trpv1), but that are devoid of
CpG islands in the rat genome. Therefore, we did not investigate
these genes in our study. Recently, it has been shown that also
methylation changes in enhancer regions of the DNA [62], as well
as the CpG island shores [63], may induce differences between
subjects, providing another regulatory region in which DNA
methylation plays a role in the regulation of transcription. The
general relevance of these findings, however, needs to be
confirmed in future studies.
Overall conclusion
In conclusion, our results show that DNA methylation of the rat
genes we studied is variable, tissue specific and cannot be
extrapolated from leukocytes to other tissues. On the other hand,
we observed a high degree of concordance between human and
rat DNA methylation in leukocytes, suggesting that it is possible to
study effects on DNA methylation in rat tissues that are difficult to
obtain from humans, for example several types of brain tissues.
The large variation of DNA methylation in the Crcp, Calcrl, Esr1
and Nos3 genes suggests that these genes are prone to changes in
DNA methylation, but challenges drawing conclusions about the
effect of 17b-estradiol.
Supporting Information
File S1 Figure S1. Example of standard curve, showing the
distribution of methylation of the known samples for the Esr1 gene.
Table S1. Body weight (g) and bodyweight changes (D, g) in rats
after different treatments (n = 11–14). * p,0.05 compared to
OVX placebo. Differences were calculated using one-way
ANOVA. Table S2. Estradiol and CGRP concentrations
measured at day 1, day 7 and day 21 and progesterone
concentrations measured at day 21. * p,0.05 compared to both
sham and OVX animals treated with placebo pellet. Differences
were calculated using one-way ANOVA.
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